European Journal of Preventive Cardiology and secondary cardiovascular prevention and sport cardiology. It publishes 18 issues yearly and abstracted and indexed in Scopus and the Social Sciences Citation Index. According to the "Journal Citation Reports", its 2016 impact factor is 3.6, ranking it 43th out of 125 journals in the category "Cardiac & Cardiovascular Systems". Areas of interests are Cardiovascular primary and secondary preventions, (including arterial hypertension, dyslipidaemia, diabetes, obesity, smoking cessation, healthy life style promotion), epidemiology, cardiac rehabilitation, exercise training and physiology, sport cardiology, population science intervention. European Journal of Preventive Cardiology The European Journal of Preventive Cardiology is a peer-reviewed medical journal that
Cardiovascular disease disease. The use of aspirin in people, who are otherwise healthy, is of unclear benefit. Cardiovascular diseases are the leading cause of death globally. This is true in all areas of the world except Africa. Together they resulted in 17.9 million deaths (32.1%) in 2015, up from 12.3 million (25.8%) in 1990. Deaths, at a given age, from CVD are more common and have been increasing in much of the developing world, while rates have declined in most of the developed world since the 1970s. Coronary artery disease and stroke account for 80% of CVD deaths in males and 75%